Home › New AbbVie hepatitis C regimen shows high cure rates: studies
 

Keywords :   


New AbbVie hepatitis C regimen shows high cure rates: studies

2016-04-16 14:49:17| Biotech - Topix.net

An experimental once-daily combination hepatitis C treatment being developed by AbbVie Inc demonstrated very high cure rates across a wide range of disease genotypes, according to data presented on Saturday, likely giving the company a more competitive product if approved. Cure rates of 97 percent to 100 percent over either eight or 12 weeks of treatment were achieved in the clinical trials with the one pill, once-a-day combination of ABT-493 and ABT-530, which use different methods to block virus replication.

Tags: high shows rates studies

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.05Melting Massage Bar Patented by Johnson & Johnson
03.05How the computer games industry is embracing AI
03.05Apple sees biggest fall in sales for a year
02.05Turkey halts trade with Israel over Gaza 'tragedy'
02.05Loop Industries and Ester Ltd. Announce Joint Venture
02.05The Oldham Group names Hunter Collins account manager
02.05NCBAs Sigrid Johannes promoted to Senior Director of Government Affairs
02.05University helps neighboring ranchers oust redcedars
More »